Valeant completes Salix Pharmaceuticals acquisition

Valeant Pharmaceuticals International has completed the acquisition of Salix Pharmaceuticals.

Advertisement

Salix Pharmaceuticals focuses on the gastroenterology market. The company offers treatments such as XIFAXAN, RUCONEST, APRISO, UCERIS and RELISTOR.

More articles on gastroenterology:
5 most-read GI articles – March 23 to March 27
4 recent GI market updates to know
18 statistics on gastroenterologist habits & burnout

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.